Avantor, Inc. (NYSE:AVTR) Short Interest Update

Avantor, Inc. (NYSE:AVTR) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 24,520,000 shares, a drop of 8.9% from the November 30th total of 26,930,000 shares. Based on an average daily trading volume, of 5,960,000 shares, the short-interest ratio is presently 4.1 days.

Institutional Investors Weigh In On Avantor

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Hantz Financial Services Inc. increased its stake in Avantor by 2.1% in the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock worth $644,000 after purchasing an additional 503 shares during the period. Intech Investment Management LLC increased its stake in shares of Avantor by 1.8% in the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock worth $616,000 after buying an additional 514 shares during the period. Arizona State Retirement System increased its stake in shares of Avantor by 0.3% in the second quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock worth $3,955,000 after buying an additional 528 shares during the period. Veracity Capital LLC raised its holdings in Avantor by 1.0% during the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock valued at $1,355,000 after buying an additional 543 shares during the last quarter. Finally, US Bancorp DE boosted its position in Avantor by 6.2% during the 3rd quarter. US Bancorp DE now owns 12,615 shares of the company’s stock valued at $326,000 after buying an additional 734 shares during the period. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the subject of several recent analyst reports. Barclays reduced their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. UBS Group decreased their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Wells Fargo & Company decreased their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Finally, Robert W. Baird dropped their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $27.69.

Avantor Trading Down 0.0 %

NYSE AVTR traded down $0.01 during trading on Wednesday, hitting $21.07. 2,308,260 shares of the company’s stock traded hands, compared to its average volume of 6,358,581. The stock has a fifty day moving average of $21.63 and a two-hundred day moving average of $23.34. Avantor has a 12-month low of $19.59 and a 12-month high of $28.00. The firm has a market cap of $14.34 billion, a P/E ratio of 45.80, a PEG ratio of 2.75 and a beta of 1.29. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.